IL-22, a cytokine of the IL-10 family, whose levels increase in colonic tissues and in the peripheral blood of IBD patients (76), was found to increase TJs permeability (54, 77) by downregulating the expression of both ZO-1 and E-cadherin (78). This evidence concerns the gene CDH1 and inflammatory bowel disease.